Helen Greta

Oct 1, 2024 | clinicalleader.com | Dan Schell |Helen Greta |Cenduit IRT

With ICH M11 expected to be adopted by the end of the year, the next Clinical Leader Live digital event will host a panel discussion on the advantages of improving and simplifying the dataflow of clinical trials but also the challenges associated with creating a connected digital dataflow, including digital health channels, that spans from protocol to data collection to CSR. Register today and join us on 10/31 at 1 pm ET (10 am PT).

May 29, 2024 | clinicalleader.com | Helen Greta |Cenduit IRT |Ian Davison

How Can We Improve Clinical Trial Feasibility Processes? Clinical Leader Live uncovers how experts work to overcome frustrations in the feasibility and site selection process for clinical trials. Hear from speakers from J&J Innovative Medicines, Takeda, and CSL Behring on ways they’ve been able to improve the feasibility assessment process. Reserve your spot today for this May 30th digital event. Registration is free thanks to the support of inSeption Group.

Feb 13, 2024 | clinicalleader.com | Monica Roy |Helen Greta |Cenduit IRT

CLINICAL TRIAL TECHNOLOGYQuick Tips And Hot Takes For Selecting Clinical Trial TechnologyAvoid inefficient decision-making that keeps key downstream activities in limbo and select a new clinical trial technology efficiently with this technology selection guide. Why Aren’t More Sites Moving To eSource? In this segment, TF Pharma's Robert Goldman talks about different views of what eSource is and how, in some instances, this clinical trial technology doesn’t save any time over using paper.

Apr 27, 2023 | ecmconnection.com | Helen Greta

By Helen Greta, Director, Project Management at Cenduit IRT, an IQVIA business In recent years, clinical trials have undergone a widespread adoption of mobile devices, sensors, and wearables through patient-centric Decentralized Trials (DCT). Not only has the shift in trial design improved patient enrollment and participation rates, but the new technologies have also provided researchers with a large volume of data and insights.

Apr 25, 2023 | clinicalleader.com | Helen Greta

By Helen Greta, Director, Project Management at Cenduit IRT, an IQVIA business In recent years, clinical trials have undergone a widespread adoption of mobile devices, sensors, and wearables through patient-centric Decentralized Trials (DCT). Not only has the shift in trial design improved patient enrollment and participation rates, but the new technologies have also provided researchers with a large volume of data and insights.